3 news items
Bristol Myers Squibb, Taye Diggs and Schizophrenia Community Partner to Empower People with Schizophrenia Through Live Your PosSCZible Campaign
BMY
21 May 24
.
Schizophrenia is a persistent and often disabling mental illness impacting how a person thinks, feels and behaves, with onset typically occurring in late teens
Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic Outcomes Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society
BMY
6 Apr 24
Schizophrenia
Schizophrenia is a persistent and often disabling mental illness impacting how a person thinks
Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society
BMY
6 Apr 24
.
About Schizophrenia
Schizophrenia is a persistent and often disabling mental
- Prev
- 1
- Next